Macular Abnormalities Associated With 5α-Reductase Inhibitor-Reply

JAMA Ophthalmol. 2021 Feb 1;139(2):252-253. doi: 10.1001/jamaophthalmol.2020.5774.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • 5-alpha Reductase Inhibitors* / adverse effects
  • Humans
  • Oxidoreductases
  • Retina*

Substances

  • 5-alpha Reductase Inhibitors
  • Oxidoreductases